Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage
Pragya D. Yadav, Deepak Y. Patil(ICMR-National Institute of Virology), Varsha Potdar(ICMR-National Institute of Virology), Shreekant Baradkar(ICMR-National Institute of Virology), Savita Patil(ICMR-National Institute of Virology), Jayshri Pethani(Smt. N.H.L. Municipal Medical College), Rima R. Sahay(ICMR-National Institute of Virology), Dimpal A. Nyayanit(ICMR-National Institute of Virology), Prasad Sarkale(ICMR-National Institute of Virology)
Cited by 52
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268
Prevalence of SARS-CoV-2 infection in India
|The Indian Journal of Medical Research|2020|225